For a Better Interpretation of Quality of Life Scores of Kidney Transplant Patients: Determination of the Minimum Significant Change RetransQol
This trial is active, not recruiting.
|Treatment||answering specific quality of life questionnaire in kidneys transplantation population|
|Sponsor||Assistance Publique Hopitaux De Marseille|
|Start date||January 2012|
|End date||March 2015|
|Trial size||2000 participants|
|Trial identifier||NCT02870374, 2012-15, 2012-A00634-39|
The project team developped and validated a French patient-based health-related quality of life instrument in kidney transplant: the QoL Retrans.
The aim of the study is to determine the minimum significant change of the valdiated tool: ReTransQol
Number of change in quality of life in kidneys transplantation patients using ReTransQol
time frame: 1 year
Male or female participants at least 18 years old.
Inclusion Criteria: - Patient with a transplant kidney Exclusion Criteria: - Patient not able to answer survey
|Principal investigator||Stéphanie GENTILE, MD/PhD|
Call for more information